David D. Allen

2.1k total citations
27 papers, 1.7k citations indexed

About

David D. Allen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, David D. Allen has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in David D. Allen's work include Neuroscience and Neuropharmacology Research (11 papers), Drug Transport and Resistance Mechanisms (7 papers) and Trace Elements in Health (5 papers). David D. Allen is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Drug Transport and Resistance Mechanisms (7 papers) and Trace Elements in Health (5 papers). David D. Allen collaborates with scholars based in United States, Chile and France. David D. Allen's co-authors include Paul R. Lockman, Robert A. Yokel, Eric P. Sandgren, Ralph L. Brinster, Mary R. Avarbock, R D Palmiter, Joanna Koziara, Russell J. Mumper, Peter A. Crooks and Janelle S. Crossgrove and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David D. Allen

26 papers receiving 1.6k citations

Peers

David D. Allen

CMN

GENET

Stefania Crispi Italy

Jianyong Wang China

Alfeu Zanotto‐Filho Brazil

Jian‐Hong Zhu China

Trevor W. Sweatman United States

Won Sik Eum South Korea

Carla Biondi Italy

Sabine Hüwel Germany

Qian Guo China

Ying Song China

Stefania Crispi Italy

David D. Allen

943 ×1.3

94 ×0.4

217 ×0.9

CMN

149 ×0.7

GENET

208 ×1.2

Citations per year, relative to David D. Allen David D. Allen (= 1×) peers Stefania Crispi

Countries citing papers authored by David D. Allen

Since Specialization

Citations

This map shows the geographic impact of David D. Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Allen more than expected).

Fields of papers citing papers by David D. Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Allen. The network helps show where David D. Allen may publish in the future.

Co-authorship network of co-authors of David D. Allen

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Allen. A scholar is included among the top collaborators of David D. Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Allen. David D. Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geldenhuys, Werner J. & David D. Allen. (2012). The Blood-Brain Barrier Choline Transporter. Central Nervous System Agents in Medicinal Chemistry. 12(2). 95–99. 16 indexed citations

Lockman, Paul R., Vamshi K. Manda, Werner J. Geldenhuys, et al.. (2007). Carrier-Mediated Transport of the Quaternary Ammonium Neuronal Nicotinic Receptor Antagonist N,N′-Dodecylbispicolinium Dibromide at the Blood-Brain Barrier. Journal of Pharmacology and Experimental Therapeutics. 324(1). 244–250. 21 indexed citations

Deuther‐Conrad, Winnie, J. T. Patt, Paul R. Lockman, et al.. (2007). Norchloro-fluoro-homoepibatidine (NCFHEB) — A promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET. European Neuropsychopharmacology. 18(3). 222–229. 19 indexed citations

Koziara, Joanna, Paul R. Lockman, David D. Allen, & R. J. Mumper. (2006). The Blood-Brain Barrier and Brain Drug Delivery. Journal of Nanoscience and Nanotechnology. 6(9). 2712–2735. 67 indexed citations

Geldenhuys, Werner J., et al.. (2005). Inhibition of choline uptake byN-cyclohexylcholine, a high affinity ligand for the choline transporter at the blood–brain barrier. Journal of drug targeting. 13(4). 259–266. 4 indexed citations

Allen, David D., Raúl Caviedes, Ana M. Cárdenas, et al.. (2005). Cell Lines as In Vitro Models for Drug Screening and Toxicity Studies. Drug Development and Industrial Pharmacy. 31(8). 757–768. 96 indexed citations

Crooks, Peter A., Joshua T. Ayers, Rui Xu, et al.. (2004). Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release. Bioorganic & Medicinal Chemistry Letters. 14(8). 1869–1874. 29 indexed citations

Allen, David D. & Paul R. Lockman. (2003). The blood-brain barrier choline transporter as a brain drug delivery vector. Life Sciences. 73(13). 1609–1615. 57 indexed citations

Allen, David D., Paul R. Lockman, Karen E. Roder, Linda P. Dwoskin, & Peter A. Crooks. (2003). Active Transport of High-Affinity Choline and Nicotine Analogs into the Central Nervous System by the Blood-Brain Barrier Choline Transporter. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1268–1274. 51 indexed citations

10.

Lockman, Paul R., Joanna Koziara, Karen E. Roder, et al.. (2003). In Vivo and in Vitro Assessment of Baseline Blood-Brain Barrier Parameters in the Presence of Novel Nanoparticles. Pharmaceutical Research. 20(5). 705–713. 78 indexed citations

11.

Koziara, Joanna, Paul R. Lockman, David D. Allen, & Russell J. Mumper. (2003). In Situ Blood–Brain Barrier Transport of Nanoparticles. Pharmaceutical Research. 20(11). 1772–1778. 142 indexed citations

12.

Allen, David D. & Quentin R. Smith. (1999). Blood–brain barrier choline transport in the senescent rat. Neuroscience Letters. 277(3). 198–202. 18 indexed citations

13.

Yokel, Robert A., et al.. (1999). The distribution of aluminum into and out of the brain. Journal of Inorganic Biochemistry. 76(2). 127–132. 69 indexed citations

14.

Allen, David D., et al.. (1996). The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethyl-, 1,2 diethyl-, and 1-[ethan-1′ ol]-2-methyl-3-hydroxypyridin-4-one in the rat. Toxicology. 108(3). 191–199. 80 indexed citations

15.

Chang, Michael, Eric Grange, Olivier Rabin, et al.. (1996). Lithium decreases turnover of arachidonate in several brain phospholipids. Neuroscience Letters. 220(3). 171–174. 129 indexed citations

16.

Allen, David D., et al.. (1996). Hippocampal Acetylcholine Increases During Eyeblink Conditioning in the Rabbit. Physiology & Behavior. 60(5). 1199–1203. 20 indexed citations

17.

Allen, David D., et al.. (1996). Evaluation of 4,4′‐diisothiocyanatostilbene‐2,2′‐disulfonic acid in the inhibition of rouleaux formation. Transfusion. 36(2). 109–112. 4 indexed citations

18.

Allen, David D., Chris Orvig, & Robert A. Yokel. (1994). Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy. Toxicology. 92(1-3). 193–202. 12 indexed citations

19.

Yokel, Robert A., et al.. (1994). Studies of aluminum neurobehavioral toxicity in the intact mammal. Cellular and Molecular Neurobiology. 14(6). 791–808. 35 indexed citations

20.

Allen, David D., Peter A. Crooks, & Robert A. Yokel. (1992). 4-trimethylammonium antipyrine: A quaternary ammonium nonradionuclide marker for blood-brain barrier integrity during in vivo microdialysis. Journal of Pharmacological and Toxicological Methods. 28(3). 129–135. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact